1st Jul 2013 15:46
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 28 June 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £16.39 per Ordinary Share, and notional ADSs at a price of $49.95 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2013 to 30 June 2013:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 2,593.045 | |
Professor Sir Roy Anderson | 552.929 | |
Dr Stephanie Burns |
| 462.187 |
Stacey Cartwright | 438.530 | |
Lynn Elsenhans | 831.937 | |
Judy Lewent | 391.854 | |
Sir Deryck Maughan | 1,083.369 | |
Dr Daniel Podolsky | 873.536 | |
Tom de Swaan | 514.796 | |
Jing Ulrich | 291.379 | |
Hans Wijers | 324.131 | |
Sir Robert Wilson | 477.501 | |
The Company and the Non-Executive Directors were informed of these allocations on 1 July 2013.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 July 2013
Related Shares:
Glaxosmithkline